Product logins

Find logins to all Clarivate products below.


Traumatic Brain Injury | Niche and Rare Pharmacor | G7 | 2015

A sudden, mechanical head injury that disrupts brain function is termed traumatic brain injury (TBI). Motor vehicle accidents, violence, and falls are the most common causes of TBI. Symptoms such as headache, fatigue, and mood changes can occur across TBI severities. However, in moderate to severe TBI these symptoms may be compounded by progressively worsening headaches, inability to awaken from sleep, agitation, and seizures, among others. Disabilities resulting from TBI depend on the extent of brain damage—cognition deficits and mental health problems are common; in the extreme, severe TBI patients may be in a vegetative state. With no neuroprotective therapies currently available, the treatment goal in TBI is to prevent further brain damage. Surgery may be required for brain hematomas or contusions, and moderate to severe cases require rehabilitation tailored to patients’ specific TBI manifestations.

Related Market Assessment Reports

Report
Traumatic Brain Injury – Epidemiology – Epidemiology – Traumatic Brain Injury – Mature markets
Clarivate Epidemiology’s coverage of traumatic brain injury comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France,…
Report
Traumatic Brain Injury | Executive Insights | US | 2020
TBI is a major cause of death and disability in the United States; DRG Epidemiology estimates that there were 250,000 moderate to severe TBI events diagnosed in U.S. hospitals / emergency rooms in…
Report
Age-Related Macular Degeneration | Pharmacor | G7 | 2015
Last Updated 30 December 2015 In late age-related macular degeneration (AMD), vision deficits are noticeable, often debilitating, and can be a precursor to blindness. The availability of vascular…
Report
Acute Lymphoblastic Leukemia | Niche and Rare Pharmacor | G7 | 2015
Acute lymphoblastic leukemia (ALL), also known as acute lymphoid leukemia or cancer of the white blood cells, develops from lymphocytes overproduced in the bone marrow that spread to other sites…
Report
Hepatitis C Virus (Emerging Market Special Report) | Emerging Markets | China | 2015
Hepatitis C virus (HCV) is the leading cause of end-stage liver disease and hepatocellular carcinoma in China. The prevalence of this chronic disease remains high owing to the presence of a large…